The global ureteral stents market continues to gain momentum as urological disorders rise in prevalence and healthcare systems increasingly prioritize minimally invasive treatment options. Ureteral stents-small, flexible tubes inserted into the ureter to relieve obstructions-play a crucial role in managing kidney stones, ureteral strictures, postoperative swelling, and various malignancies. Over the past decade, improvements in stent materials, coatings, and design have significantly enhanced patient comfort and reduced complications such as encrustation and infection. Healthcare providers are adopting more advanced stenting solutions as part of broader efforts to improve quality of care, reduce readmission rates, and support faster patient recovery. As a result, the market is experiencing sustained growth driven by both technological innovation and a rising global burden of urological diseases.
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=25988
Market Size and Growth
According to recent industry assessments, the global ureteral stents market was
valued at US$ 488.2 million in 2022 and is on track for substantial expansion
over the coming decade. Driven by rising surgical volumes, improved access to
healthcare, and continuous product innovation, the market is projected to grow
at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2031. By the end
of the forecast period, the market is expected to reach more than US$ 823.7
million by 2031. This growth reflects not only a higher incidence of urological
disorders but also advancements in minimally invasive urology procedures,
including ureteroscopy and percutaneous nephrolithotomy. Furthermore, increased
awareness and early diagnosis of urological conditions in emerging markets are
expanding the potential customer base for ureteral stent manufacturers.
Market Segmentation
The ureteral stents market can be segmented by material type, product design,
application, and end user. In terms of materials, polymer-based
stents-including polyurethane, silicone, and hybrid materials-continue to
dominate the market due to their flexibility, affordability, and favorable
compatibility with patient tissue. Metallic stents represent a smaller but
growing segment, especially for patients requiring long-term stenting
solutions. By product design, the market includes double-J stents, multi-loop
stents, and specialty stents designed for oncology or chronic obstruction
management. Double-J stents remain the most widely used due to their
effectiveness in preventing stent migration. Applications for ureteral stents
span kidney stone management, ureteral stricture treatment, postoperative
management, and prevention of obstruction caused by tumors. End users primarily
include hospitals, ambulatory surgical centers, and specialty urology clinics,
with hospitals accounting for the largest share due to higher patient volumes
and access to advanced imaging and surgical tools.
Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/ureteral-stents-market.html
Regional Analysis
From a geographical perspective, North America remains the leading market for
ureteral stents, supported by high rates of kidney stone incidence, robust
healthcare infrastructure, and rapid adoption of advanced urology technologies.
The United States, in particular, demonstrates strong market demand thanks to
high procedural volumes and increased focus on patient-centric device
innovations. Europe follows closely, with countries such as Germany, France,
and the U.K. seeing consistent growth due to aging populations and
well-established reimbursement frameworks. Asia-Pacific, however, is poised for
the most rapid growth throughout the forecast period, driven by expanding
healthcare access, rising awareness of urological health, and increasing
medical tourism in countries such as India, China, and Thailand. Meanwhile,
emerging markets in Latin America and the Middle East & Africa are
gradually strengthening their position through improved healthcare investments
and the establishment of advanced urology departments.
Competitive Landscape
The ureteral stents market is characterized by a strong competitive landscape
with several global manufacturers focusing on technological leadership, product
expansion, and strategic collaboration. Major players include Boston Scientific
Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Americas,
Coloplast Corporation, Merit Medical Systems, Inc., and Becton, Dickinson, and
Company. These companies continue to invest in R&D to develop
next-generation stent materials, patient-friendly designs, and specialized
stents for complex medical conditions. Competitive strategies in the market
often involve acquisitions, new product launches, portfolio diversification,
and partnerships with healthcare providers and distributors. As competition
intensifies, innovation and product differentiation will become essential for
maintaining market share.
About Transparency Market Research
Transparency Market Research, a global market research company registered at
Wilmington, Delaware, United States, provides custom research and consulting
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insights for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants use proprietary data
sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research
experts, so that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453